Literature DB >> 9813012

Crystal structure of the ligand binding domain of the human nuclear receptor PPARgamma.

J Uppenberg1, C Svensson, M Jaki, G Bertilsson, L Jendeberg, A Berkenstam.   

Abstract

The peroxisome proliferator-activated receptors (PPAR) are members of the nuclear receptor supergene family and are considered as key sensors of both lipid and glucose homeostasis. The role of the PPARgamma isoform in glucose metabolism is illustrated by the fact that anti-diabetic thiazolidinediones have been shown to be bona fide PPARgamma ligands. Here we report the crystal structure of apo-PPARgamma ligand binding domain (LBD) determined to 2.9-A resolution. Although the structure of apo-PPARgamma-LBD retains the overall fold described previously for other nuclear receptor LBDs, three distinct structural differences are evident. 1) The core AF-2 activation domain of apo-PPARgamma LBD is folded back toward the predicted ligand binding pocket similar to that observed in the holo-forms of other nuclear receptors. 2) The proposed ligand binding pocket of apo-PPARgamma-LBD is larger and more accessible to the surface in contrast to other LBDs. 3) The region of the LBD called the omega-loop is extended in PPARgamma and contains additional structural elements. Taken together, the apo-PPARgamma-LBD structure is in several aspects different from previously described LBDs. Given the central role of PPARgamma as a mediator in glucose regulation, the structure should be an important tool in the development of improved anti-diabetic agents.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9813012     DOI: 10.1074/jbc.273.47.31108

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Peroxisome proliferator-activated receptors target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.

Authors:  Bernard Pirard
Journal:  J Comput Aided Mol Des       Date:  2003-11       Impact factor: 3.686

Review 2.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

3.  A two-stage differential hydrogen deuterium exchange method for the rapid characterization of protein/ligand interactions.

Authors:  Michael J Chalmers; Scott A Busby; Bruce D Pascal; Mark R Southern; Patrick R Griffin
Journal:  J Biomol Tech       Date:  2007-09

Review 4.  The orphan nuclear receptors at their 25-year reunion.

Authors:  Shannon E Mullican; Joanna R Dispirito; Mitchell A Lazar
Journal:  J Mol Endocrinol       Date:  2013-11-26       Impact factor: 5.098

5.  Dynamics of nuclear receptor Helix-12 switch of transcription activation by modeling time-resolved fluorescence anisotropy decays.

Authors:  Mariana R B Batista; Leandro Martínez
Journal:  Biophys J       Date:  2013-10-01       Impact factor: 4.033

6.  Ligand-escape pathways from the ligand-binding domain of PPARgamma receptor as probed by molecular dynamics simulations.

Authors:  D Genest; N Garnier; A Arrault; C Marot; L Morin-Allory; M Genest
Journal:  Eur Biophys J       Date:  2007-10-11       Impact factor: 1.733

7.  A novel role for helix 12 of retinoid X receptor in regulating repression.

Authors:  J Zhang; X Hu; M A Lazar
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

8.  Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.

Authors:  Anne-M Krogsdam; Curt A F Nielsen; Søren Neve; Dorte Holst; Torben Helledie; Bo Thomsen; Christian Bendixen; Susanne Mandrup; Karsten Kristiansen
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

9.  Sulindac derivatives that activate the peroxisome proliferator-activated receptor gamma but lack cyclooxygenase inhibition.

Authors:  Andrew S Felts; Brianna S Siegel; Shiu M Young; Christopher W Moth; Terry P Lybrand; Andrew J Dannenberg; Lawrence J Marnett; Kotha Subbaramaiah
Journal:  J Med Chem       Date:  2008-07-30       Impact factor: 7.446

10.  Virtual Screening as a Technique for PPAR Modulator Discovery.

Authors:  Stephanie N Lewis; Josep Bassaganya-Riera; David R Bevan
Journal:  PPAR Res       Date:  2009-09-02       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.